Phase IV Study of FDA Approved, Once-Daily GRALISE™(Gabapentin) Tablets for the Treatment of Postherpetic Neuralgia

Completed

Conditions studied: Post Herpetic Neuralgia

In brief

Study objective is to assess the safety and effectiveness of once- daily GRALISE in clinical practice

Key facts

Study ID

NCT01426230

Run by

Depomed

People needed

201

Starts

2011-09-01

Expected to finish

2012-04-01

Last updated by the study team

2013-03-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men or Women 18 years or older who are suffering from PHN

You may not qualify if…

• Patient is Pregnant or a nursing mother
• Patient has hypersensitivity to gabapentin
• Patient has an estimated creatinine clearance of <30 mL/min or is in hemodialysis

Where it is running

• Study site — Mobile, Alabama, United States
• Study site — Tuscaloosa, Alabama, United States
• Study site — Phoenix, Arizona, United States
• Study site — Sun City, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Fresno, California, United States
• Study site — San Francisco, California, United States
• Study site — Fairfield, Connecticut, United States
• Study site — Lauderdale Lakes, Florida, United States
• Study site — Naples, Florida, United States
• Study site — North Palm Beach, Florida, United States
• Study site — Ormond Beach, Florida, United States
• Study site — Palm Beach, Florida, United States
• Study site — Sunrise, Florida, United States
• Study site — Marietta, Georgia, United States
• Study site — Bolingbrook, Illinois, United States
• Study site — Evansville, Indiana, United States
• Study site — Lexington, Kentucky, United States
• Study site — Brighton, Massachusetts, United States
• Study site — Worcestor, Massachusetts, United States
• Study site — Jefferson City, Missouri, United States
• Study site — St Louis, Missouri, United States
• Study site — Tom River, New Jersey, United States
• Study site — Hickory, North Carolina, United States
• Study site — Raleigh, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.